| Product Code: ETC9977203 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States experienced a notable shift in its sterile injectable import landscape in 2024, with top exporting countries including Israel, Belgium, Japan, Sweden, and Denmark. The market showed a transition from very low to low concentration, indicating increased diversification in import sources. Despite a challenging CAGR of -21.67% from 2020 to 2024, the growth rate in 2024 saw a significant improvement with a decline of -59.13% compared to the previous year. This data suggests a dynamic and evolving market environment for sterile injectables in the US, with potential opportunities for further expansion and diversification in the future.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Sterile Injectable Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Sterile Injectable Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Sterile Injectable Market - Industry Life Cycle |
3.4 United States (US) Sterile Injectable Market - Porter's Five Forces |
3.5 United States (US) Sterile Injectable Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.6 United States (US) Sterile Injectable Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 United States (US) Sterile Injectable Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
3.8 United States (US) Sterile Injectable Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United States (US) Sterile Injectable Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Sterile Injectable Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring injectable medications |
4.2.2 Technological advancements in injectable drug delivery systems |
4.2.3 Growing demand for biologics and biosimilars |
4.2.4 Rising geriatric population leading to higher healthcare utilization |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for manufacturing and approval of sterile injectables |
4.3.2 Price pressures and cost containment efforts in the healthcare sector |
4.3.3 Lack of skilled professionals for sterile injectable manufacturing |
4.3.4 Product recalls and quality control issues impacting market reputation |
5 United States (US) Sterile Injectable Market Trends |
6 United States (US) Sterile Injectable Market, By Types |
6.1 United States (US) Sterile Injectable Market, By Molecule Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Sterile Injectable Market Revenues & Volume, By Molecule Type, 2021- 2031F |
6.1.3 United States (US) Sterile Injectable Market Revenues & Volume, By Large Molecule, 2021- 2031F |
6.1.4 United States (US) Sterile Injectable Market Revenues & Volume, By Small Molecule, 2021- 2031F |
6.2 United States (US) Sterile Injectable Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Sterile Injectable Market Revenues & Volume, By Monoclonal Antibodies (mAbs), 2021- 2031F |
6.2.3 United States (US) Sterile Injectable Market Revenues & Volume, By Cytokines, 2021- 2031F |
6.2.4 United States (US) Sterile Injectable Market Revenues & Volume, By Insulin, 2021- 2031F |
6.2.5 United States (US) Sterile Injectable Market Revenues & Volume, By Peptide Hormones, 2021- 2031F |
6.2.6 United States (US) Sterile Injectable Market Revenues & Volume, By Vaccines, 2021- 2031F |
6.2.7 United States (US) Sterile Injectable Market Revenues & Volume, By Immunoglobulins, 2021- 2031F |
6.2.8 United States (US) Sterile Injectable Market Revenues & Volume, By Peptide Antibiotics, 2021- 2031F |
6.2.9 United States (US) Sterile Injectable Market Revenues & Volume, By Peptide Antibiotics, 2021- 2031F |
6.3 United States (US) Sterile Injectable Market, By Therapeutic Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Sterile Injectable Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.3 United States (US) Sterile Injectable Market Revenues & Volume, By Metabolic Diseases, 2021- 2031F |
6.3.4 United States (US) Sterile Injectable Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.5 United States (US) Sterile Injectable Market Revenues & Volume, By Central Nervous Systems Disorders, 2021- 2031F |
6.3.6 United States (US) Sterile Injectable Market Revenues & Volume, By Infectious Disorders, 2021- 2031F |
6.3.7 United States (US) Sterile Injectable Market Revenues & Volume, By Musculoskeletal Disorders, 2021- 2031F |
6.4 United States (US) Sterile Injectable Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Sterile Injectable Market Revenues & Volume, By Subcutaneous (SC), 2021- 2031F |
6.4.3 United States (US) Sterile Injectable Market Revenues & Volume, By Intravenous (IV), 2021- 2031F |
6.4.4 United States (US) Sterile Injectable Market Revenues & Volume, By Intramuscular (IM), 2021- 2031F |
6.4.5 United States (US) Sterile Injectable Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Sterile Injectable Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Sterile Injectable Market Revenues & Volume, By Hospitals Pharmacies, 2021- 2031F |
6.5.3 United States (US) Sterile Injectable Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 United States (US) Sterile Injectable Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 United States (US) Sterile Injectable Market Import-Export Trade Statistics |
7.1 United States (US) Sterile Injectable Market Export to Major Countries |
7.2 United States (US) Sterile Injectable Market Imports from Major Countries |
8 United States (US) Sterile Injectable Market Key Performance Indicators |
8.1 Number of FDA approvals for new sterile injectable drugs |
8.2 Adoption rate of advanced injectable drug delivery technologies |
8.3 Growth in demand for biologics and biosimilars in the US market |
8.4 Rate of compliance with regulatory standards for sterile injectable manufacturing |
8.5 Number of adverse events or product recalls in the sterile injectable market |
9 United States (US) Sterile Injectable Market - Opportunity Assessment |
9.1 United States (US) Sterile Injectable Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.2 United States (US) Sterile Injectable Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 United States (US) Sterile Injectable Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
9.4 United States (US) Sterile Injectable Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United States (US) Sterile Injectable Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Sterile Injectable Market - Competitive Landscape |
10.1 United States (US) Sterile Injectable Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Sterile Injectable Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here